Drug intelligence / Profile preview

Hyaluvance

Development stage
Unknown
Lead developer
BMG Pharma
Modality
Nanoparticles → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems, Device-based Delivery → Drug Delivery Systems
Administration
Topical, Intradermal
01

Overview

Hyaluvance is an aesthetic medical product line developed by BMG Pharma, based on its proprietary Hyaluromimethic Technology. This technology involves the covalent chemical modification of hyaluronic acid (sodium hyaluronate) on its hydroxylic groups to create biocompatible biomaterials with enhanced stability and biological properties. The product line is designed for professional aesthetic medicine, specifically for skin rejuvenation and mesotherapy. Formulations like Hyaluvance Golden combine modified hyaluronic acid with components of the extracellular matrix and regenerative activators to support skin health and provide anti-aging effects. These products are intended for cosmetic and aesthetic medicine applications rather than therapeutic disease treatment.

Brand names
HyaluvanceHyaluvance Golden
Other names
Hyaluvance aesthetic line

Beyond the preview

Go deeper on Hyaluvance.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyaluvance.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call